Real-world treatment outcomes and clinicopathologic determinants of response for patients with advanced thyroid cancer treated with first-line lenvatinib.

Authors: Kara Marie Ruicci, Yangqing Deng, Tian Xiao, Antoine Eskander, David Paul Goldstein, Ozgur Mete, Aruz Mesci, Jelena Lukovic, Monika K. Krzyzanowska, Carly C. Barron, Lucy Xiaolu Ma

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e18132

Source: Full article

---

Abstract

e18132